AMSTERDAM, Oct 29 (Reuters) - U.S. healthcare group Johnson & Johnson (JNJ.N) said on Friday it stood by its bid for Crucell (CRCL.AS)(CRXL.O) after the Dutch biotechnology firm halted shipments of two vaccines pending an investigation.
AMSTERDAM, Oct 29 (Reuters) - U.S. healthcare group Johnson & Johnson (JNJ.N) said on Friday it stood by its bid for Crucell (CRCL.AS)(CRXL.O) after the Dutch biotechnology firm halted shipments of two vaccines pending an investigation.
